Patent · US Expired

Protein tyrosine kinase agonist antibodies

US6331302A · kind A · utility

15Cited by
3References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 23, 1996
Grant dateDec 18, 2001
Priority date
Expiry dateMay 23, 2016

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Agonist antibodies are disclosed which bind to the extracellular domain of receptor protein tyrosine kinases pTKs, and thereby cause dimerization and activation of the intracellular tyrosine kinase domain thereof. The antibodies are useful for activating their respective receptor and thereby enabling the role of the tyrosine kinase receptor in cell growth and/or differentiation to be studied. Chimeric proteins comprising the extracellular domain of the receptor pTKs and an immunoglobulin constant domain sequence are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.